Pymaceuticals Analysis
Seth Pruitt

1) Capomulin routinely out-performed both the placebo and the other two analyzed drugs, Infubinol and Ketapril.

2) A majority of drugs have no significant difference vs the placebo.

3) Plotting the other drugs would likely have provided different outcomes to analyze. Ramicane, for example, was able to routinely outperform Capomulin.